ABC Network Tonight Vaccine-Autism Connection

Politics, World and National Events, Commentary, Alternative Health, "Emmes" means "Truth."
That headline covered a story under "Briefly" in Monday's Los Angeles Times Health section. I thought it was a joke to see if I was paying attention to what I was reading. Days after the debacle over Zetia and Vytorin study results not being reported by Merck and Schering-Plough, it seemed too coincidental that more drug studies were either kept secret, or worse yet, fudged to cover up the deleterious effects of the drugs:
Nearly one-third of antidepressant drug studies are never published in the medical literature, and nearly all happen to show that the drug being tested did not work, researchers reported Wednesday in the New England Journal of Medicine.
And in some of the studies that are published, unfavorable results have been recast to make the medicine appear more effective than it really is, said the research team led by Erick Turner of the Oregon Health & Science University.
Even if not deliberate, they wrote in their report, "Selective publication can lead doctors to make inappropriate prescribing decisions that may not be in the best interest of their patients."
Yesterday and today Merck and Schering-Plough took out two-page ads in the Los Angeles Times touting the wonders of Zetia and Vytorin and recommending following the advice of physicians with the assumption that the almighty result of lowering ldl cholesterol was a sufficient end in itself, regardless of the unhappy build-up of the killer plaque in arteries was also caused by these drugs.
High cholesterol levels in the blood have been blamed through the years on higher cases of arterial disease based largely on statistical correlation. The exact mechanism of plaque build-up in arteries is still not completely understood. Systemic "inflammation" may be a culprit, as well as high cholesterol levels, and the statin drugs may also have an effect on this inflammation which is helpful along with the lowering of serum cholesterol levels. And just which element of the cholesterol picture--low density lipoproteins (ldl) or high-density lipoproteins (hdl) or very low density lipoproteins (vldl)--is the "good" or "bad" cholesterol is all based on educated theory, some empirical and some statistical.
The Zetia/Vytorin ads state unequivocally that the ldl cholesterol is "bad" cholesterol. While this is probably true, it would be beneficial to the consumer in order to be well-informed, to know of the theoretical essence of such a statement.
I have received some antagonistic emails in the past in response to my commentary on pharmaceutical companies' deceitful practices. They were not published because of their inflammatory nature and uninformed opinions. However, when media reports continue to grow about the greed and illegal activities of drug manufacturers, it seems specious to argue about how wonderful these products really are. The one thing that is for sure, is that the bottom line for big pharma is the big buck, not public health.
Democratic contender Barack Obama has scheduled a "roundtable on economic opportunity" at a private home in Van Nuys tomorrow afternoon. He's also got a fundraiser Wednesday night at the Pacific Palisades home of Marianna and David Fisher, with co-hosts including Tom Unterman, Zeb Rice, Ted Field and others. It's the usual $2,300 requested per person and $25,000 for the co-hosts.
What more can this president do to curry favor with the Saudis? He forgave them for nurturing the Wahhabism that spawned al-Qaida, and he never embarrasses them with the fact that bin Laden and 15 of the19 hijackers who attacked America on 9/11 were born and raised in the kingdom. Nor did Bush let the inconvenient fact that the Saudi government had backed the Taliban until 9/11 intrude on his cozy relations with the royal family. That warmth, displayed at ranching cookouts in both countries, has now been reinforced by $20
billion in U.S. arms sales to the Saudis and their Persian Gulf allies,
officially announced by Bush on Monday.At first, the Bush administration feared that some pro-Israel members of Congress might be able to derail the arms sale deal, but they solved that one by offering Israel $30 billion in new weapons. That’s a good deal for the Israelis and for U.S. arms manufacturers, although not for U.S. taxpayers stuck with the tab. No problem—neither the media nor Congress notices the cost to taxpayers of anything carrying the label of “national security.” Heck, Iraq’s defense minister was just in Washington with his shopping list for new weapons and didn’t cause much of a stir when he said the United States will have to defend Iraq for at least a decade more. So much for the impact of the $1 trillion already wasted on the Iraq debacle.
It doesn’t get any sillier. Until you read that the Food and Drug Administration says that food from cloned animals is safe. The FDA is the government agency that allows, among others, the ubiquitous seasoning MSG (monosodium glutamate), known to cause physical and nerve issues in millions of people, to continue to be approved. This is not even to mention the reams of cases of FDA conflict of interest in drug and vaccine approvals due to the immense force of big pharma lobby money. When people actually start to eat cloned animals, “silly” may become a major understatement of the situation.…the government demanded that the scientists, in order to get the badges, fill out questionnaires on their personal lives and waive the privacy of their financial, medical and psychiatric records. The government also wanted permission to gather information about them by interviewing third parties.
In other words, as the price of keeping their jobs, many of America's finest space scientists were being asked to give the feds virtually blanket permission to snoop and spy and collect even malicious gossip about them from God knows who.
Investigators wanted license to seek information as to whether "there is any reason to question [applicants'] honesty or trustworthiness." At one point, JPL's internal website posted an "issue characterization chart" -- since taken down -- that indicated the snoops would be looking for "patterns of irresponsible behavior as reflected in credit history ... sodomy ... incest ... abusive language ... unlawful assembly ... homosexuality." (We'll leave it to others to explain a standard that links incest with unlawful assembly.)
Meanwhile, the results "raise some very interesting questions," said Dr. P.K. Shah, a cardiologist at Cedars-Sinai Medical Center who was not involved in the study.
"Is the LDL hypothesis still alive and well after this?" he asked.
"Despite a 17-percentage-point reduction in LDL, [Vytorin] did not produce any changes better than the single drug alone. Many of us had not quite expected it to be that way."
Ya think? $5 bil is at stake!Results of the two-year study had originally been scheduled to be released in 2006, but the companies delayed them, saying that the analysis was extremely complex. At one point, the firms said they were going to change the study's design to simplify analysis, but critics objected and the researchers returned to their original plans.
Last month, the U.S. House of Representatives' Committee on Energy and Commerce launched an investigation into why the results
had not been released sooner.Critics had charged that the delays were the result of negative findings.